Global Migraine Drug Market Outlook

Migraine is a clinical condition related to painful headaches and other symptoms such as nausea, sensitivity to smell, and others. These headaches generally occur on one side of the head and each episode of migraine has a different duration and intensity. Migraine drugs are employed in the treatment of headaches associated with migraine. The global migraine drugs market was valued at $1,714 million in 2019 and is expected to reach $2,180 million by 2028, growing at a CAGR of 4.1% from 2019 to 2028.



Top Driver: increase in female population and surge in awareness among patients related to prevention and treatment of migraine
The increasing awareness regarding migraine and various options available for its treatment are the main factors boosting the expansion of the worldwide migraine drugs market. A number of organizations including the American Headache and Migraine Association are taking efforts to spread awareness about migraine and hence coming up with programs and providing support to patients so as to spread awareness regarding the disease and further disorders related to a headache. Due to the increasing number of migraine incidences and rising number of unmet needs in the global migraine drugs market, a number of companies are planning to invest in the migraine drugs R&D. This, in turn, is anticipated to propel the global migraine drugs market growth shortly.

The rise in the pervasiveness of migraine drives the migraine drugs market. Moreover, the increase in the female population and surge in awareness among patients related to prevention and treatment of migraine are the key factors that augment the growth of the market. However, side effects associated with migraine drugs are a factor that hinders market growth. On the contrary, the presence of growth opportunities in emerging nations is expected to provide new opportunities for the key players.

Triptans Make Crucial Contribution to Growth of Global Migraine Drug Market
Based on Therapeutics, i.e. Triptans, Acetylcholine Inhibitors/ neurotoxins, Ergot Alkaloids, NSAIDs. Triptans are expected to grow in the forecasting year 2028. Because, Unlike other acute medications, triptans are considered selective serotonin receptor agonists, meaning that triptans work by stimulating serotonin, a neurotransmitter found in the brain, to reduce inflammation and constrict blood vessels, thereby stopping the headache or migraine.

Based on treatment the market can be segmented by treatment into acute/abortive treatment and preventive/ prophylactic treatment. Acute treatment includes therapeutic classes such as triptans, ergot alkaloids, NSAIDs, and other non-specific drugs prescribed over-the-counter (OTC) such as aspirin, acetaminophen, and ibuprofen. The therapeutic classes are diversified through the route of administration with drugs available as oral, injectable, nasal spray, and others.

Preventive/prophylactic treatment includes prescription of off-label and generic medications including beta-blockers such as atenolol and propranolol, anti-epileptics such as topiramate, and divalproex sodium. Currently, Allergan’s Botox (neurotoxin), Amgen/ Novartis’s Aimovig, and Teva’s Ajovy (CGRP mAb) are the sole drugs approved for migraine prevention. However, Botox requires more than 30 injections across the forehead, shoulders, and neck and does not provide relief from episodic migraine.

Rising Investments in Global Migraine Drug Market Benefit to Asia Pacific Market
The Asia Pacific is anticipated to dominate the worldwide migraine drugs market and is further expected to continue this trend within the near future. This high growth is mainly owing to the increasing number of people having a migraine and raising public awareness of the disease in this region. In addition, China and India are the main developing countries contributing to the worldwide migraine drugs market growth within the Asia Pacific region; this is often mainly thanks to the high occurrence of migraine in these countries. Rising specialization in niche products and their launches alongside high penetration of novel drug manufacturers will further have a positive impact on the expansion of the worldwide migraine drugs market in the near future.

The market in North America is expected to govern the global migraine drugs market, owing to suffering from migraine diseases and relatively more health-conscious populations.
Players to Focus on Expanding Global Migraine Drug Market
Certain key players in the market are Pfizer, GlaxoSmithKline, Allergan, Amgen, Eli Lilly, Teva Pharma, Biohaven Pharma, Johnson & Johnson, and Valeant Pharma.
Until 2017, Allergan’s Botox, a neurotoxin was in a strong competitive position in the preventive migraine market. As the only drug sanctioned for prevention, Botox commanded premium pricing with more than 60.0% market share

Botox: in 2017 Botox is anticipated to face competition from the launch of Amgen/Novartis’ Aimovig and other highly efficacious CGRP-based therapies, which target both chronic and episodic migraine, as opposed to Botox, which is only approved for the chronic variant of the condition.
Aimovig’s: Aimovig’s launch at a lower than expected price will facilitate patient access and help drive drug sales in the preventive migraine space, which is expected to be teeming and competitive within the entry of CGRP mAbs from Teva Pharma, Eli Lilly, and Alder.

Scope of the Report
By treatment Type
• Acute / Abortive Treatment
• Preventive/ Prophylactic Treatment
By Therapeutic
• Triptans
• Acetylcholine Inhibitors/ neurotoxins
• Ergot Alkaloids
• NSAID
By Route of Administration
• Oral
• Injectables
• Others
By Region
• North America
• Europe
• Asia Pacific
• Rest Of World

Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation

Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted

Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary

Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis

Chapter 5 Global Migraine Drug Market Forces
5.1 What’s Driving the Market
5.2 Porter’s Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition

Chapter 6 Global Migraine Drug Market -Industry Snapshots
6.1 Overview
6.1.1 Global Migraine Drug Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis

Chapter 7 Global Migraine Drug Market Analysis, by Treatment
7.1 Overview
7.2 Key Findings for Migraine Drug Market- By Treatment
7.2.1 Migraine Drug Market- Acute / Abortive Treatment
7.2.2 Migraine Drug market by Treatment 1, 2019 - 2028 (USD Million)
7.2.3 Migraine Drug Market- Preventive/ Prophylactic Treatment

Chapter 8 Global Migraine Drug Market Analysis, by Therapeutitc
8.1 Overview
8.2 Key Findings for Migraine Drug Market- By Product Type
8.2.1 Migraine Drug Market- Triptans
8.2.2 Migraine Drug Market- Acetylcholine inhibitors
Migraine Drug market by Therapeutic 2, 2019 - 2028 (USD Million)
8.2.3 Migraine Drug Market- Ergot Alkoloids
8.2.4 Migraine Drug Market- NSAID

Chapter 9 Global Migraine Drug Market Analysis, by Route of Administration
9.1 Overview
9.2 Key Findings for Migraine Drug Market- Route of Administration
9.2.1 Migraine Drug Market- Oral
9.2.2 Migraine Drug Market- Injectables
9.2.3 Migraine Drug Market- Others

Chapter 10 Migraine Drug Market Analysis by Region
10.1 Key Findings for Migraine Drug Market- By region
10.2 Overview
10.2.1 Global Migraine Drug Market Analysis, By Type, 2019 - 2028
10.2.2 Global Migraine Drug Market Analysis, By Product Type, 2019 - 2028
10.2.3 Global Migraine Drug Market Analysis, By End User, 2019 - 2028
10.3 Migraine Drug Market – North America
10.3.1 Overview
10.3.2 U.S.
10.3.3 Canada
10.3.4 Mexico
10.3.5 North America Market, By Type
10.3.6 North America Market, By Product Type
10.3.7 North America Market, By End User
10.4 Migraine Drug Market – Europe
10.4.1 Overview
10.4.2 Germany
10.4.3 United Kingdom
10.4.4 France
10.4.5 Italy
10.4.6 Rest Of Europe
10.4.7 Europe Market, By Type
10.4.8 Europe Market, By Product Type
10.4.9 Europe market by, End User
10.5 Migraine Drug Market – Asia Pacific
10.5.1 Overview
10.5.2 China
10.5.3 Japan
10.5.4 India
10.5.5 Rest of APAC
10.5.6 Asia Pacific Market, By Type
10.5.7 Asia Pacific Market, By Product Type
10.5.8 Asia Pacific Market, By End User
10.6 Migraine Drug Market – Rest Of World
10.6.1 Overview
10.6.2 Middle East & Africa (MEA)
10.6.3 South America
10.6.4 Rest Of World
10.6.5 South America, Middle East and Africa Market, By Type
10.6.6 South America, Middle East and Africa Market, By Product Type
10.6.7 South America, Middle East and Africa Market, By End User

Chapter 11 Market Competition Analysis
11.1 Market Share/Positioning Analysis
11.1.1 Market Positioning of Key Vendors, 2019
11.1.2 Key Strategies Adopted by the Leading Players
11.1.3 Recent Developments

Chapter 12 Company Profiles- Snapshot
12.1.1 Pfizer
12.1.2 Business Fundamentals
12.1.3 Financial Snapshots
12.1.4 Product Portfolio
12.1.5 Recent Developments
12.2 GlaxoSmithKline
12.3 Allergan
12.4 Amgen
12.5 Eli Lilly
12.6 Teva Pharma
12.7 Biohaven Pharma
12.8 Johnson & Johnson
12.9 Valeant Pharma
12.10 Botox
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies

Chapter 13 Appendix

List Of Tables

TABLE 1 Migraine Drug market by Treatment 2, 2019 - 2028 (USD Million)
TABLE 2 Migraine Drug market by Product Type 1, 2019 - 2028 (USD Million)
TABLE 3 Migraine Drug market by Therapeutic 3, 2019 - 2028 (USD Million)
TABLE 4 Migraine Drug market by Therapeutic 4, 2019 - 2028 (USD Million)
TABLE 5 Migraine Drug market by Route of Administration 1, 2019 - 2028 (USD Million)
TABLE 6 Migraine Drug market by Route of administration 2, 2019 - 2028 (USD Million)
TABLE 7 Migraine Drug market by Route of administration 3, 2019 - 2028 (USD Million)
TABLE 8 Global Migraine Drug Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 9 Global Migraine Drug Market Value, By Product Type, 2019 - 2028 (US$ Bn)
TABLE 10 Global Migraine Drug Market Value, By End User, 2019 - 2028 (US$ Bn)
TABLE 11 Migraine Drug Market Analysis by North America (USD Million), 2019 - 2028
TABLE 12 U.S. Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 13 U.S. Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 14 U.S. Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 15 U.S. Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 16 Canada Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 17 Canada Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 18 Canada Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 19 Canada Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 20 Mexico Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 21 Mexico Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 22 Mexico Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 23 Mexico Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 24 Migraine Drug Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 25 Germany Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 26 Germany Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 27 Germany Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 28 Germany Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 29 United Kingdom Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 30 United Kingdom Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 31 United Kingdom Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 32 United Kingdom Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 33 France Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 34 France Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 35 France Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 36 France Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 37 Italy Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 38 Italy Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 39 Italy Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 40 Italy Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 41 Rest Of Europe Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 42 Rest Of Europe Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 43 Rest Of Europe Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 44 Rest of Europe Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 45 Migraine Drug Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 46 China Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 47 China Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 48 China Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 49 China Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 50 Japan Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 51 Japan Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 52 Japan Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 53 Japan Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 54 India Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 55 India Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 56 India Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 57 India Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 58 Rest of APAC Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 59 Rest of APAC Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 60 Rest of APAC Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 61 Rest of APAC Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 62 Migraine Drug Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 63 Middle East & Africa (MEA) Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 64 Middle East & Africa (MEA) Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 65 Middle East & Africa (MEA) Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 66 Middle East & Africa (MEA) Market, By End User, 2019 - 2028 (USD Million)
TABLE 67 South America Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 68 South America Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 69 South America Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 70 South America Migraine Drug Market, By End User, 2019 - 2028 (USD Million)
TABLE 71 Rest Of World Migraine Drug Market, 2019 - 2028 (USD Million)
TABLE 72 Rest Of World Migraine Drug Market, By Type, 2019 - 2028 (USD Million)
TABLE 73 Rest Of World Migraine Drug Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 74 Rest Of World Migraine Drug Market, By End User, 2019 - 2028 (USD Million)

List Of Figures

FIG. 1 Global Migraine Drug : Market Segmentation
FIG. 2 Global Migraine Drug Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porter’s Five Forces Analysis
FIG. 6 Global Migraine Drug Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Migraine Drug Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Migraine Drug Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 10 Global Migraine Drug Market Value Contribution, By End User, 2019 & 2026 (%)
FIG. 11 Global Migraine Drug Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 North America Migraine Drug Market Value, 2019 - 2028, (US$ Bn)
FIG. 13 Migraine Drug Market Segment 1 – North America
FIG. 14 Migraine Drug Market Segment 2 – North America
FIG. 15 Migraine Drug Market Segment 3 – North America
FIG. 16 Migraine Drug U.S. outlook, 2019 & 2026
FIG. 17 Migraine Drug Canada outlook, 2019 & 2026
FIG. 18 Migraine Drug Mexico outlook, 2019 & 2026
FIG. 19 Europe Migraine Drug Market Value, 2019 - 2028, (US$ Bn)
FIG. 20 Migraine Drug Market Segment 1 – Europe
FIG. 21 Migraine Drug Market Segment 2 – Europe
FIG. 22 Migraine Drug Market Segment 3 – Europe
FIG. 23 Migraine Drug Germany outlook, 2019 & 2026
FIG. 24 Migraine Drug United Kingdom outlook, 2019 & 2026
FIG. 25 Migraine Drug France outlook, 2019 & 2026
FIG. 26 Migraine Drug Italy outlook, 2019 & 2026
FIG. 27 Migraine Drug Rest Of Europe outlook, 2019 & 2026
FIG. 28 Asia Pacific Migraine Drug Market Value, 2019 - 2028, (US$ Bn)
FIG. 29 Migraine Drug Market Segment 1 – Asia Pacific
FIG. 30 Migraine Drug Market Segment 2 – Asia Pacific
FIG. 31 Migraine Drug Market Segment 2 – Asia Pacific
FIG. 32 Migraine Drug China outlook, 2019 & 2026
FIG. 33 Migraine Drug Japan outlook, 2019 & 2026
FIG. 34 Migraine Drug India outlook, 2019 & 2026
FIG. 35 Migraine Drug Rest of APAC outlook, 2019 & 2026
FIG. 36 Rest Of World Migraine Drug Market Value, 2019 - 2028, (US$ Bn)
FIG. 37 Migraine Drug Market Segment 1 – Rest Of World
FIG. 38 Migraine Drug Market Segment 2 – Rest Of World
FIG. 39 Migraine Drug Market Segment 3 – Rest Of World
FIG. 40 Migraine Drug Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 41 Migraine Drug South America outlook, 2019 & 2026
FIG. 42 Migraine Drug Rest Of World outlook, 2019 & 2026

Fill The Form For Sample Request

There is no Reviews available